Lista de obras -

A pediatric case of hepatitis B virus subgenotype A2 in Japan

artículo científico publicado en 2013

Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene ⬇️

artículo científico publicado el 1 de septiembre de 2011

Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load

artículo científico publicado en 2010

Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis

artículo científico publicado en 2008

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy

artículo científico publicado en 2011

Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness

artículo científico publicado en 2015

Biochemical staging of the chronic hepatic lesions of Wilson disease

artículo científico publicado en 2014

Causes of vertical transmission of hepatitis B virus under the at-risk prevention strategy in Japan.

artículo científico publicado en 2013

Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy

artículo científico publicado en 2005

Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy

artículo científico publicado en 2016

Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFN alpha-2b

artículo científico publicado en 2009

Comparison of contrast-enhanced harmonic ultrasonography and power Doppler ultrasonography for depicting vascularity of hepatocellular carcinoma identified by angiography-assisted CT

artículo científico publicado en 2003

Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan

artículo científico publicado en 2007

Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders

artículo científico publicado en 2012

Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

artículo científico publicado en 2015

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

artículo científico publicado en 2007

Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

artículo científico publicado en 2009

Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.

artículo científico publicado en 2007

Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy

scientific article published on 30 July 2018

Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy

artículo científico publicado en 2009

Mutations of the interferon sensitivity-determining region (ISDR) correlate with the complexity of hypervariable region (HVR)-1 in the Japanese variant of hepatitis C virus (HCV) type 1b.

artículo científico publicado en 2004

Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B.

artículo científico publicado en 2013

Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b ⬇️

artículo científico publicado el 1 de enero de 2012

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains

artículo científico publicado en 2010

Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan

artículo científico publicado en 2004

Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin

artículo científico publicado en 2012

Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia

artículo científico publicado en 2008

Week 4 viral response to peginterferon and ribavirin: how should it be used in combination with a baseline predictive factor?

artículo científico publicado en 2012

Lista de obras de

A pediatric case of hepatitis B virus subgenotype A2 in Japan

Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene ⬇️

Association between HCV amino acid substitutions and outcome of peginterferon and ribavirin combination therapy in HCV genotype 1b and high viral load

Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy

Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness

Biochemical staging of the chronic hepatic lesions of Wilson disease

Causes of vertical transmission of hepatitis B virus under the at-risk prevention strategy in Japan.

Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy

Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy

Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFN alpha-2b

Comparison of contrast-enhanced harmonic ultrasonography and power Doppler ultrasonography for depicting vascularity of hepatocellular carcinoma identified by angiography-assisted CT

Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan

Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders

Effect of peginterferon alfa-2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C.

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.

Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy

Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy

Mutations of the interferon sensitivity-determining region (ISDR) correlate with the complexity of hypervariable region (HVR)-1 in the Japanese variant of hepatitis C virus (HCV) type 1b.

Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B.

Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b ⬇️

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains

Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan

Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin

Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia

Week 4 viral response to peginterferon and ribavirin: how should it be used in combination with a baseline predictive factor?